Aspex Management (HK)’s Lam Research LRCX Stock Holding History

Aspex Management (HK)’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-399,641	Closed	-$53.5M	–	28
2025 Q3	$53.5M	Buy	+399,641	New	+$42.3M	1.13%	17
2024 Q3	–	Sell	-1,849,610	Closed	-$197M	–	35
2024 Q2	$197M	Sell	1,849,610 -289,120	-14%	-$27.7M	4.21%	10
2024 Q1	$208M	Sell	2,138,730 -541,130	-20%	-$47.6M	5.56%	6
2023 Q4	$210M	Sell	2,679,860 -148,850	-5%	-$10.1M	6.15%	7
2023 Q3	$177M	Sell	2,828,710 -2,280,640	-45%	-$150M	5.46%	8
2023 Q2	$328M	Buy	5,109,350 +1,409,350	+38%	+$79.4M	9.55%	4
2023 Q1	$196M	Buy	3,700,000 +400,000	+12%	+$19.6M	4.82%	7
2022 Q4	$139M	Sell	3,300,000 -2,700,000	-45%	-$113M	3.83%	10
2022 Q3	$220M	Buy	6,000,000 +200,000	+3%	+$8.9M	6.48%	6
2022 Q2	$247M	Buy	5,800,000 +5,100,000	+729%	+$243M	6.19%	9
2022 Q1	$37.6M	Buy	+700,000	New	+$40.7M	1.49%	17
2021 Q4	–	Sell	-2,629,070	Closed	-$150M	–	29
2021 Q3	$150M	Hold	2,629,070	–	–	4.98%	7
2021 Q2	$171M	Hold	2,629,070	–	–	5.6%	5
2021 Q1	$156M	Buy	2,629,070 +128,000	+5%	+$6.97M	6.2%	6
2020 Q4	$118M	Hold	2,501,070	–	–	4.66%	9
2020 Q3	$83M	Sell	2,501,070 -833,690	-25%	-$28.7M	5.33%	9
2020 Q2	$108M	Buy	+3,334,760	New	+$90.9M	13.23%	3

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aspex Management (HK)'s LRCX Position: Q4 2025 in Review

Aspex Management (HK) sold out of Lam Research (LRCX) in Q4 2025, closing a stake of 399,641 shares — an estimated $53.5M sold.

Aspex Management (HK) first reported a position in LRCX in Q2 2020 and held it in 17 quarters. The position peaked at $328M in Q2 2023. 2,391 funds tracked by Wall St. Rank hold LRCX as of Q4 2025.

Aspex Management (HK) reported no remaining Lam Research position as of Q4 2025 after selling out during the quarter.
Aspex Management (HK) sold 399,641 Lam Research shares in Q4 2025, an estimated $53.5M.
Aspex Management (HK) first reported a position in Lam Research in Q2 2020 and held it in 17 quarters.
Aspex Management (HK)'s Lam Research position peaked at $328M in Q2 2023.
2,391 funds tracked by Wall St. Rank held Lam Research as of Q4 2025.

Based on Aspex Management (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.